Stem Cell Therapy Market is expected to grow at a double digit CAGR over the forecast period.
Market Industry Reports (MIR) has published a new report titled “Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report The global stem cell therapy market was valued at over US$ 103 Mn in 2018 and is expected to witness a double digit CAGR during the forecast period.
The major factors driving the growth of the market includes increasing burden of chronic diseases, growing investment in R&D, and technological developments in biotech and pharmaceutical industry.
Increasing burden of chronic diseases to boost the market growth
Increasing global burden of diseases such as diabetes, cancer, and others are projected to be the major factors leading to the market growth. According to the World Health Organization (WHO) in 2017, number of patients suffering from type I and type II diabetes was estimated to be over 422 million. Moreover, the disease is expected to be the seventh largest cause of death by 2030.
According to American Cancer Society, in 2017, there were over 1.6 million new cancer cases in the U.S. Hence, there exists a need for developing new treatment methods which have led to the rise in approvals of clinical trials for the stem cell based therapies.
Stem cells to be the future of regenerative medicine
Stem cells possess the regenerative quality which has been utilized for the treatment of various diseases such as diabetes. Recently in 2018, Scientists at Cincinnati Children’s Center for Stem Cell and Organoid Medicine (CuSTOM) have artificially grown esophagus tissues in the research laboratory using the pluripotent stem cells. These lab grown esophagi are expected to help treat a range of condition including gastro esophageal reflux disease, esophageal cancer, esophageal atresia, esophageal achalasia and various others.
Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal disorders, Cardiovascular Diseases, Gastrointestinal Diseases, Wounds and Injuries, Surgeries) - Global Forecast to 2023 - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/stem-cell-therapy-market/32
High cost of Stem cell Therapy to restrict the market growth
Stem cell transplantation is expensive as being the multiple step process which includes isolating adult stem cells, diagnosis, re-administering, and post treatment care with follow-ups. Moreover, the high initial investment due to the high cost of instrument used in developing stem cell therapy is the major factors restricting the growth of the market. Moreover, not all costs associated with the treatment are allocated at the time of practice, hidden costs including the graft versus host disease, reaction to treatment, or disability resulting from the treatment can lead to more costs and additional treatments.
Major Players in the market focusing on R&D
Players are focusing on R&D to develop new treatment for diseases by using stem cells. For Instant, Center for stem cell biology and Regenerative Medicine is currently working with the University of Tokyo, to develop regenerative medicine by utilizing ERATO Nakauchi stem cells to treat organ failure.
Key players operating in the global stem cell Therapy market are Osiris, MEDIPOST, Anterogen, PHARMICELL Co., Ltd, Holostem Terapie Avanzate S.r.l.JCR Pharmaceuticals Co., NuVasive, Inc., RTI Surgical, Inc , and AlloSource
Market Industry Reports is a global leader in market measurement and advisory services. It is 100% subsidiary of Maniks Systems Pvt Ltd. The firm has always been at the forefront of innovation to address the worldwide industry trends and opportunities.
We offer our clients a unique depth of market intelligence in an actionable format to move their business forward. Our analysis incorporates the consumer study in more than 100 countries that provide a tactical approach to drive the sustained growth for the business. We continue to pioneer state-of theart approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.